You are here

Article info

Article menu
Download PDFPDF
Editorial
Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage

Authors

  • Kai-Feng Xu Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Xinlun Tian Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Yanli Yang Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Hongbing Zhang Department of Physiology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kai-Feng Xu, Department of Respiratory Medicine, Peking Union Medical College Hospital, Beijing, China; xukf{at}pumch.cn
View Full Text

Citation

Xu K, Tian X, Yang Y, et al
Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage
Thorax 2018;73:308-310.

Publication history

  • First published February 2, 2018.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.